1. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (N.A.M., F.K.K., F.N., Y.G., R.P.G., M.S.S., C.T.R.).
2. Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard Cambridge, MA (C.R., S.A.L., P.T.E.).
3. University Medical Center Groningen, University of Groningen, the Netherlands (C.R.).
4. National Heart and Lung Institute, Imperial College London, United Kingdom (P.S.S.).
5. Oslo University Hospital, Ulleval and Medical Faculty, University of Oslo, Norway (T.R.P.).
6. Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia (A.C.K.).
7. Amgen, Thousand Oaks, CA (H.W., A.L.P.).
8. Cardiovascular Research Center, Massachusetts General Hospital, Boston (S.A.L., P.T.E.).